The ACR Research and Education Foundation (REF) has launched “Within Our Reach,” a national, multiyear, $30-million fundraising campaign aimed at accelerating innovative research on rheumatoid arthritis. RA—long considered one of the most disabling types of arthritis—has been a primary focus of rheumatologic research. Recent advances in the basic management of RA include targeted treatments and improvements in treating other types of inflammatory arthritis. Unfortunately, we still do not know the cause of RA or have a cure.
Search results for: statin
Combine With Medicare Part D to Help Patients Afford Prescriptions
According to the 2003 U.S. Census, 29 million people in the United States make less than 200% of the federal poverty level and have no health insurance. Many persons have difficulty affording prescribed medications. In addition to Medicare Part D, there are more than 350 public and private patient assistance programs, including programs by pharmaceutical companies, that help patients pay for prescriptions.
Payments Cut to the Bone
CMS reduces reimbursement for DXA and vertebral fracture assessment
Joint by Joint
X-ray expert John Sharp, MD, revolutionized RA tracking with the Sharp score
A Heart In Danger
Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis
- « Previous Page
- 1
- …
- 35
- 36
- 37